Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABMT OTCMKTS:ADMT OTCMKTS:AKSY OTCMKTS:MDIT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABMTAdvanced Biomedical Technologies$0.00$0.00▼$0.00N/AN/A500 shsN/AADMTADM Tronics Unlimited$0.10$0.06$0.05▼$0.10$6.56M0.0117,598 shs59,000 shsAKSYAksys$0.00$0.00▼$0.00N/AN/AN/AN/AMDITCytoCore$0.01$0.00$0.01▼$0.01N/A101.87929 shsN/AAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABMTAdvanced Biomedical Technologies0.00%0.00%0.00%-75.00%-83.33%ADMTADM Tronics Unlimited0.00%+29.85%+97.96%+83.02%+2.11%AKSYAksys0.00%0.00%0.00%0.00%0.00%MDITCytoCore0.00%0.00%+4,900.00%+4,900.00%+4,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABMTAdvanced Biomedical Technologies$0.00$0.00▼$0.00N/AN/A500 shsN/AADMTADM Tronics Unlimited$0.10$0.06$0.05▼$0.10$6.56M0.0117,598 shs59,000 shsAKSYAksys$0.00$0.00▼$0.00N/AN/AN/AN/AMDITCytoCore$0.01$0.00$0.01▼$0.01N/A101.87929 shsN/AAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABMTAdvanced Biomedical Technologies0.00%0.00%0.00%-75.00%-83.33%ADMTADM Tronics Unlimited0.00%+29.85%+97.96%+83.02%+2.11%AKSYAksys0.00%0.00%0.00%0.00%0.00%MDITCytoCore0.00%0.00%+4,900.00%+4,900.00%+4,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABMTAdvanced Biomedical Technologies 0.00N/AN/AN/AADMTADM Tronics Unlimited 0.00N/AN/AN/AAKSYAksys 0.00N/AN/AN/AMDITCytoCore 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABMTAdvanced Biomedical Technologies$270KN/AN/AN/AN/AN/AADMTADM Tronics Unlimited$3.20M2.05N/AN/A$0.01 per share9.70AKSYAksysN/AN/AN/AN/AN/AN/AMDITCytoCoreN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABMTAdvanced Biomedical Technologies-$510KN/A0.00N/AN/AN/AN/AN/AN/AADMTADM Tronics Unlimited-$120KN/A0.00∞N/A-2.05%-7.88%-3.00%11/12/2025 (Estimated)AKSYAksysN/AN/A0.00N/AN/AN/AN/AN/AN/AMDITCytoCoreN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AADMTADM Tronics UnlimitedN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/AMDITCytoCoreN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABMTAdvanced Biomedical TechnologiesN/AN/AN/AADMTADM Tronics UnlimitedN/A1.200.85AKSYAksysN/AN/AN/AMDITCytoCoreN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABMTAdvanced Biomedical TechnologiesN/AADMTADM Tronics UnlimitedN/AAKSYAksysN/AMDITCytoCoreN/AInsider OwnershipCompanyInsider OwnershipABMTAdvanced Biomedical Technologies34.11%ADMTADM Tronics Unlimited73.00%AKSYAksys3.80%MDITCytoCore85.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABMTAdvanced Biomedical Technologies20N/AN/ANot OptionableADMTADM Tronics Unlimited2367.59 million18.25 millionNot OptionableAKSYAksys87N/AN/ANot OptionableMDITCytoCore71N/AN/ANot OptionableMDIT, ADMT, ABMT, and AKSY HeadlinesRecent News About These CompaniesMDIT Medite Cancer Diagnostics, Inc.May 29, 2025 | seekingalpha.comMedite Cancer Diagnostics, Inc. (MDIT)November 23, 2024 | finance.yahoo.comKing Charles's Cancer Diagnosis and Treatment TimelineApril 29, 2024 | townandcountrymag.comTCancer Diagnostics – Webinars and Online EventsApril 16, 2024 | technologynetworks.comTA cancer diagnosis is a shock. Here's advice on how to share the newsMarch 30, 2024 | kunm.orgKAbout Pancreatic CancerMarch 14, 2024 | bcm.eduBNew Diagnostic Techniques for Breast Cancer DetectionFebruary 8, 2024 | medscape.comMTargeted Optical Contrast Agents for Cancer DiagnosticsJanuary 30, 2024 | medscape.comMPancreatic Cancer Resource CenterNovember 14, 2023 | webmd.comWPatient Navigation in Breast Cancer: A Systematic ReviewOctober 24, 2023 | medscape.comMCleveland Diagnostics Announces Prostate Cancer Awareness Month Campaign: ‘A PSA on PSA’September 26, 2023 | finance.yahoo.comCancer Diagnostics – ProductsSeptember 11, 2023 | technologynetworks.comTPancreatic Cancer Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028September 2, 2023 | finance.yahoo.comBreast Cancer Diagnostics Market to Grow Rapidly at a CAGR of 8.7% by 2030 | DataM IntelligenceAugust 23, 2023 | finance.yahoo.comHere's why some people keep their cancer diagnosis to themselves: 'An incredibly personal decision'August 18, 2023 | yahoo.comCancer Diagnostics – News and FeaturesAugust 16, 2023 | technologynetworks.comTCancer DiagnosticsAugust 16, 2023 | technologynetworks.comTSimple blood test combined with risk model improves lung cancer mortality predictionJune 28, 2023 | news-medical.netNA New Urine Test Could Be a Simple Way to Check For CancerMay 10, 2023 | msn.comUrine Test Could Reveal Cancer and MetastasesMay 9, 2023 | medgadget.comMDIT, ADMT, ABMT, and AKSY Company DescriptionsAdvanced Biomedical Technologies OTCMKTS:ABMTAdvanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.ADM Tronics Unlimited OTCMKTS:ADMT$0.10 0.00 (0.00%) As of 03:38 PM EasternADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Chemical, Electronics, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. In addition, the company provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. Further, it offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Additionally, the company provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as medical electronic therapeutic technology. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey.Aksys OTCMKTS:AKSYAksys Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. The company offers an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient's blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters. It also evaluates the performance of the artificial kidney in removing toxins from the patient's blood prior to each treatment, as well as automatically evaluates the water treatment filters and indicates whether a replacement is required and verifies that safety systems, sensors, and alarms are operating correctly. Aksys Ltd. also provides various services, including the delivery and installation of the PHD System; technical services, including maintenance and repair of the PHD System; delivery of consumables used in dialysis, such as the water purification components and dialysate concentrate; and artificial kidney, and arterial and venous blood tubing. The company markets its products and services, primarily to healthcare providers, such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups in the United States, the United Kingdom, and Japan. Aksys Ltd. was founded in 1991 and is headquartered in Lincolnshire, Illinois.CytoCore OTCMKTS:MDIT$0.0050 0.00 (0.00%) As of 09/9/2025Medite Cancer Diagnostics, Inc. operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company offers USE 33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC 15 Duo and Trio, a tissue processing instrument; TES 99 and TES Valida cooling units; and M530, A550, M380 microtomes for tissue sectioning. It also provides M630, a freezing microtome; TST44, a robotic multi-staining system; COT 20, a linear staining system; and RCM 9000, ACS 720, and TWISTER robotic coverslippers. In addition, the company develops SoftKit device for the self-collection of a sample that can be evaluated to provide an assessment of the health of the entire female genital tract. It sells its products through direct sales and distributors in the United States, China, Europe, and North Africa. The company serves histology and cytology laboratories associated with hospitals or research institutions, and independent laboratories. Medite Cancer Diagnostics, Inc. is based in Orlando, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Broadcom Gets Big Upgrades: How High Analysts See Shares Going Why Micron Stock Could Outperform NVIDIA in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
